Toward the synthesis of reidispongiolide A: Stereocontrolled synthesis of the C17-C22 and C23-C35 degradation fragments

Organic Letters

Volumn 5, Issue 11, 2003, Pages 1963-1966

  Paterson, Ian ^a   Ashton, Kate ^a   Britton, Robert ^a   Knust, Henner ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMITOTIC AGENT; MACROLIDE; REIDISPONGIOLIDE A; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; KETONE;

ALDOL REACTION; ARTICLE; ASYMMETRIC SYNTHESIS; DEGRADATION; DRUG SYNTHESIS; STEREOCHEMISTRY; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SPONGE (PORIFERA); SYNTHESIS; X RAY CRYSTALLOGRAPHY;

ANIMALS; ANTINEOPLASTIC AGENTS; CRYSTALLOGRAPHY, X-RAY; KETONES; MACROLIDES; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PORIFERA;

EID: 0042352234     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol034558y     Document Type: Article

References (28)

1. Reviews: (a) Yeung, K.-S.; Paterson, I. Angew. Chem., Int. Ed. 2002, 41, 4632. (b) Spector, I.; Braet, F.; Shochet, N. R.; Bubb, M. Microsc. Res. Technol. 1999, 47, 18.
2. Reviews: (a) Yeung, K.-S.; Paterson, I. Angew. Chem., Int. Ed. 2002, 41, 4632. (b) Spector, I.; Braet, F.; Shochet, N. R.; Bubb, M. Microsc. Res. Technol. 1999, 47, 18.
3. Smith, C. D.; Carmeli, S.; Moore, R. E.; Patterson, G. M. L. Cancer Res. 1993, 53, 1343.
4. Saito, S.; Watabe, S.; Ozaki, H.; Kigoshi, H.; Yamada, K.; Fusetani, N.; Karaki, H. J. Biochem. 1996, 120, 552.
5. Zhang, X.; Minale, L.; Zampella, A.; Smith, C. D. Cancer Res. 1997, 57, 3751.
6. (a) Guella, G.; Mancini, I.; Chiasera, G.; Pietra, F. Helv. Chim. Acta 1989, 72, 237.
7. (b) D'Auria, M. V.; Gomez-Paloma, L.; Minale, L.; Zampella, A.; Verbist, J. F.; Roussakis, C.; Debitus, C. Tetrahedron 1993, 49, 8657.
8. (c) Carbonelli, S.; Zampella, A.; Randazzo, A.; Debitus, C.; Gomez-Paloma, L. Tetrahedron 1999, 55, 14665.
9. (d) D'Auria, M. V.; Gomez-Paloma, L.; Minale, L.; Zampella, A.; Verbist, J. F.; Roussakis, C.; Debitus, C.; Patissou, J. Tetrahedron 1994, 50, 4829.
10. Bassarello, C.; Bifulco, G.; Zampella, A.; D'Auria, M. V.; Riccio, R.; Gomez-Paloma, L. Eur. J. Org. Chem. 2001, 39.
11. Zampella, A.; Bassarello, C.; Bifulco, G.; Gomez-Paloma, L.; D'Auria, M. V. Eur. J. Org. Chem. 2002, 785.
12. (a) Paterson, I.; Goodman, J. M; Isaka, M. Tetrahedron Lett. 1989, 30, 7121.
13. (b) Paterson, I.; Perkins, M. V. Tetrahedron Lett. 1992, 33, 801.
14. Prepared in 3 steps (51%) from methyl (S)-2-methyl-3-hydroxypropionate in an analogous manner to the corresponding TIPS ether, see: Paterson, I.; Oballa, R. M. Tetrahedron Lett. 1997, 38, 8241.
15. For a review on asymmetric aldol reactions with boron enolates, see: Cowden, C. J.; Paterson, I. Org. React. 1997, 51, 1.
16. (a) Paterson, I.; Goodman, J. M.; Lister, M. A.; Schumann, R. C.; McClure, C. K.; Norcross, R. D. Tetrahedron 1990, 46, 4663.
17. (b) Paterson, I.; Oballa, R. M.; Norcross, R. D. Tetrahedron Lett. 1996, 37, 8581.
18. 20D recorded for synthetic 4 (+4.1, MeOH) was in accord with that reported (ref 7) for the corresponding degradation fragment. The bis-(S)-MTPA ester was also prepared for spectroscopic comparison.
19. (a) Paterson, I.; Norcross, R. D.; Ward, R. A.; Romea, P.; Lister, M. A. J. Am. Chem. Soc. 1994, 116, 11287.
20. (b) Paterson, I.; Florence, G. J.; Gerlach, K.; Scott, J. P.; Sereinig, N. J. Am. Chem. Soc. 2001, 123, 9535.
21. Evans, D. A.; Chapman, K. T.; Carreira, E. M. J. Am. Chem. Soc. 1988.
22. Oikawa, Y.; Yoshioka, T.; Yonemitsu, O. Tetrahedron Lett. 1982, 23, 889.
23. Brown, H. C.; Bhat, K. S.; Randad, R. S. J. Org. Chem. 1989, 54, 1570.
24. 3) was in accord with that previously reported. McRae, K. J.; Rizzacasa, M. A. J. Org. Chem. 1997, 62, 1196.
25. Accompanied by small amounts of the corresponding aldehyde (8%).
26. Smith, A. B., III; Cho, Y. S.; Friestad, G. K. Tetrahedron Lett. 1998, 39, 8765.
27. 13C NMR) for 5 and 6, see Supporting Information.
28. 35 degradation fragment which are in complete agreement with the data we have acquired for the alcohols 5.